Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lupus Erythematosus, Systemic | 179 | 2024 | 2152 | 27.700 |
Why?
|
Arthritis, Rheumatoid | 100 | 2024 | 3752 | 8.240 |
Why?
|
Lupus Nephritis | 26 | 2021 | 317 | 7.340 |
Why?
|
Rheumatic Diseases | 24 | 2024 | 649 | 4.470 |
Why?
|
Hydroxychloroquine | 21 | 2024 | 426 | 4.200 |
Why?
|
Rheumatology | 28 | 2024 | 615 | 3.580 |
Why?
|
Autoimmune Diseases | 19 | 2024 | 2238 | 3.420 |
Why?
|
Nurses | 26 | 2023 | 2477 | 3.250 |
Why?
|
Antirheumatic Agents | 25 | 2024 | 1365 | 3.160 |
Why?
|
Medicaid | 27 | 2024 | 2814 | 2.930 |
Why?
|
Fatty Acids, Omega-3 | 8 | 2024 | 1390 | 2.930 |
Why?
|
Antibodies, Antinuclear | 17 | 2024 | 342 | 2.690 |
Why?
|
Kidney Failure, Chronic | 13 | 2022 | 2477 | 2.260 |
Why?
|
Dietary Supplements | 13 | 2024 | 3411 | 2.250 |
Why?
|
Autoantibodies | 25 | 2024 | 2115 | 2.230 |
Why?
|
Smoking | 37 | 2022 | 9050 | 2.200 |
Why?
|
Vitamin D | 12 | 2024 | 3302 | 1.890 |
Why?
|
Immunosuppressive Agents | 16 | 2024 | 4174 | 1.740 |
Why?
|
Risk Factors | 133 | 2024 | 74115 | 1.720 |
Why?
|
Pesticides | 8 | 2024 | 296 | 1.660 |
Why?
|
Azathioprine | 6 | 2023 | 354 | 1.590 |
Why?
|
Environmental Exposure | 22 | 2024 | 4483 | 1.590 |
Why?
|
Incidence | 58 | 2024 | 21337 | 1.520 |
Why?
|
Fish Oils | 3 | 2023 | 483 | 1.390 |
Why?
|
Middle Aged | 178 | 2024 | 220584 | 1.380 |
Why?
|
Mycophenolic Acid | 4 | 2021 | 349 | 1.360 |
Why?
|
Adult | 173 | 2024 | 220969 | 1.340 |
Why?
|
Humans | 341 | 2024 | 760617 | 1.310 |
Why?
|
Insurance Benefits | 4 | 2021 | 187 | 1.310 |
Why?
|
Female | 226 | 2024 | 392148 | 1.270 |
Why?
|
United States | 91 | 2024 | 72272 | 1.270 |
Why?
|
Proportional Hazards Models | 40 | 2024 | 12447 | 1.200 |
Why?
|
Alcohol Drinking | 11 | 2020 | 4025 | 1.200 |
Why?
|
Peptides, Cyclic | 10 | 2014 | 392 | 1.160 |
Why?
|
Glucocorticoids | 11 | 2024 | 2160 | 1.160 |
Why?
|
Antiphospholipid Syndrome | 8 | 2024 | 165 | 1.090 |
Why?
|
Medication Adherence | 9 | 2022 | 2174 | 1.050 |
Why?
|
Lupus Erythematosus, Discoid | 3 | 2019 | 61 | 1.040 |
Why?
|
Healthcare Disparities | 7 | 2024 | 3351 | 1.020 |
Why?
|
Stress Disorders, Post-Traumatic | 6 | 2024 | 4575 | 0.990 |
Why?
|
Women's Health | 5 | 2021 | 2065 | 0.970 |
Why?
|
Cardiovascular Diseases | 15 | 2024 | 15498 | 0.940 |
Why?
|
Case-Control Studies | 41 | 2024 | 22148 | 0.930 |
Why?
|
Severity of Illness Index | 21 | 2021 | 15828 | 0.920 |
Why?
|
HLA Antigens | 4 | 2020 | 1329 | 0.890 |
Why?
|
Seafood | 2 | 2024 | 393 | 0.850 |
Why?
|
Prospective Studies | 64 | 2023 | 54360 | 0.850 |
Why?
|
Ultraviolet Rays | 6 | 2022 | 1079 | 0.850 |
Why?
|
Male | 131 | 2024 | 360358 | 0.840 |
Why?
|
Risk Assessment | 37 | 2024 | 23972 | 0.800 |
Why?
|
Health Resources | 2 | 2020 | 933 | 0.770 |
Why?
|
Ambulatory Care | 3 | 2021 | 2768 | 0.760 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 3 | 2014 | 64 | 0.750 |
Why?
|
Anti-Anxiety Agents | 1 | 2023 | 397 | 0.740 |
Why?
|
Aged | 81 | 2024 | 169042 | 0.720 |
Why?
|
Fishes | 1 | 2024 | 602 | 0.720 |
Why?
|
Knee Joint | 2 | 2020 | 1676 | 0.710 |
Why?
|
Complement C1q | 1 | 2020 | 93 | 0.710 |
Why?
|
Young Adult | 46 | 2024 | 59179 | 0.700 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2021 | 107 | 0.700 |
Why?
|
Cholecalciferol | 2 | 2022 | 553 | 0.700 |
Why?
|
Docosahexaenoic Acids | 2 | 2024 | 907 | 0.690 |
Why?
|
Terminology as Topic | 5 | 2018 | 1528 | 0.690 |
Why?
|
Vaccination | 3 | 2021 | 3370 | 0.690 |
Why?
|
Hospitalization | 13 | 2024 | 10704 | 0.680 |
Why?
|
Complement C3 | 2 | 2020 | 434 | 0.670 |
Why?
|
Genetic Predisposition to Disease | 24 | 2023 | 17878 | 0.660 |
Why?
|
Patient Selection | 5 | 2022 | 4237 | 0.660 |
Why?
|
Current Procedural Terminology | 1 | 2019 | 89 | 0.650 |
Why?
|
Contraceptives, Oral | 3 | 2017 | 553 | 0.630 |
Why?
|
Sex Factors | 18 | 2021 | 10548 | 0.620 |
Why?
|
Nutritive Value | 1 | 2021 | 347 | 0.610 |
Why?
|
Silicon Dioxide | 4 | 2016 | 216 | 0.610 |
Why?
|
Cyclophosphamide | 3 | 2021 | 2218 | 0.610 |
Why?
|
Cohort Studies | 37 | 2021 | 41457 | 0.610 |
Why?
|
Adolescent | 44 | 2024 | 88234 | 0.610 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2019 | 225 | 0.610 |
Why?
|
Multivariate Analysis | 21 | 2020 | 12043 | 0.610 |
Why?
|
HLA-DR Antigens | 2 | 2010 | 602 | 0.600 |
Why?
|
Minority Groups | 3 | 2022 | 1202 | 0.600 |
Why?
|
Inflammation | 7 | 2024 | 10760 | 0.600 |
Why?
|
Logistic Models | 18 | 2020 | 13245 | 0.600 |
Why?
|
Health Behavior | 7 | 2022 | 2643 | 0.590 |
Why?
|
Opportunistic Infections | 1 | 2021 | 376 | 0.590 |
Why?
|
Renal Artery | 1 | 2019 | 351 | 0.580 |
Why?
|
Patient Acceptance of Health Care | 4 | 2021 | 3194 | 0.570 |
Why?
|
Estrogen Replacement Therapy | 3 | 2016 | 1208 | 0.570 |
Why?
|
Telomere | 2 | 2016 | 940 | 0.570 |
Why?
|
Kidney Tubules | 1 | 2019 | 449 | 0.570 |
Why?
|
Chloroquine | 3 | 2024 | 274 | 0.560 |
Why?
|
Time Factors | 31 | 2024 | 39913 | 0.560 |
Why?
|
Eye Diseases | 2 | 2022 | 653 | 0.560 |
Why?
|
Pelvic Bones | 1 | 2019 | 270 | 0.560 |
Why?
|
Macrophage Activation Syndrome | 1 | 2018 | 124 | 0.550 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2018 | 190 | 0.540 |
Why?
|
Hospitals, Pediatric | 2 | 2024 | 1859 | 0.530 |
Why?
|
Consensus | 9 | 2024 | 3117 | 0.530 |
Why?
|
Humeral Fractures | 1 | 2019 | 282 | 0.530 |
Why?
|
Chemokines | 1 | 2020 | 954 | 0.520 |
Why?
|
Sleep Deprivation | 1 | 2022 | 847 | 0.510 |
Why?
|
Autoimmunity | 7 | 2024 | 1350 | 0.510 |
Why?
|
Metabolome | 3 | 2023 | 987 | 0.500 |
Why?
|
Arthritis | 2 | 2018 | 680 | 0.500 |
Why?
|
Renal Dialysis | 5 | 2022 | 1799 | 0.490 |
Why?
|
Prevalence | 15 | 2022 | 15689 | 0.490 |
Why?
|
Health Services Accessibility | 6 | 2024 | 5430 | 0.490 |
Why?
|
Cause of Death | 5 | 2021 | 3683 | 0.490 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2022 | 3244 | 0.490 |
Why?
|
Connective Tissue Diseases | 2 | 2024 | 285 | 0.480 |
Why?
|
Military Personnel | 2 | 2021 | 1245 | 0.480 |
Why?
|
Body Mass Index | 15 | 2021 | 12943 | 0.480 |
Why?
|
C-Reactive Protein | 9 | 2024 | 3822 | 0.480 |
Why?
|
Diabetes Complications | 2 | 2020 | 1315 | 0.480 |
Why?
|
Communicable Disease Control | 1 | 2021 | 846 | 0.480 |
Why?
|
Diet | 10 | 2024 | 8048 | 0.480 |
Why?
|
Depression | 3 | 2021 | 8132 | 0.480 |
Why?
|
International Classification of Diseases | 2 | 2019 | 909 | 0.480 |
Why?
|
Decision Support Techniques | 4 | 2024 | 1998 | 0.460 |
Why?
|
Infertility | 1 | 2021 | 654 | 0.450 |
Why?
|
Rheumatoid Factor | 8 | 2019 | 184 | 0.450 |
Why?
|
Vitamins | 2 | 2020 | 1635 | 0.440 |
Why?
|
Arthralgia | 1 | 2018 | 461 | 0.440 |
Why?
|
Databases, Factual | 9 | 2020 | 7960 | 0.440 |
Why?
|
Pregnancy Complications | 5 | 2021 | 2948 | 0.420 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2019 | 344 | 0.420 |
Why?
|
Societies, Medical | 9 | 2021 | 3900 | 0.420 |
Why?
|
Epitopes | 3 | 2016 | 2501 | 0.420 |
Why?
|
Chemokine CCL2 | 1 | 2015 | 602 | 0.420 |
Why?
|
Biological Products | 1 | 2022 | 912 | 0.420 |
Why?
|
Vaccines | 1 | 2021 | 838 | 0.410 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2011 | 612 | 0.410 |
Why?
|
Comorbidity | 12 | 2024 | 10505 | 0.410 |
Why?
|
Early Diagnosis | 6 | 2014 | 1185 | 0.410 |
Why?
|
Lipids | 3 | 2019 | 3332 | 0.410 |
Why?
|
Sunlight | 1 | 2014 | 337 | 0.400 |
Why?
|
Double-Blind Method | 7 | 2024 | 12334 | 0.400 |
Why?
|
Delphi Technique | 6 | 2021 | 846 | 0.390 |
Why?
|
Urban Health Services | 1 | 2012 | 176 | 0.380 |
Why?
|
Arteriosclerosis | 3 | 2005 | 1056 | 0.380 |
Why?
|
Endometriosis | 2 | 2016 | 857 | 0.370 |
Why?
|
Ophthalmology | 4 | 2022 | 550 | 0.370 |
Why?
|
Osteoarthritis, Knee | 2 | 2020 | 1234 | 0.370 |
Why?
|
Epigenesis, Genetic | 4 | 2024 | 3794 | 0.370 |
Why?
|
Hip Fractures | 1 | 2019 | 988 | 0.360 |
Why?
|
Kidney | 4 | 2021 | 7045 | 0.360 |
Why?
|
Medically Underserved Area | 1 | 2012 | 254 | 0.350 |
Why?
|
Environment | 3 | 2014 | 1123 | 0.350 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2013 | 225 | 0.340 |
Why?
|
Reproduction | 2 | 2020 | 645 | 0.330 |
Why?
|
Sjogren's Syndrome | 2 | 2024 | 237 | 0.330 |
Why?
|
Analgesics, Opioid | 4 | 2023 | 3805 | 0.330 |
Why?
|
Population Surveillance | 2 | 2019 | 2595 | 0.330 |
Why?
|
Health Status Disparities | 3 | 2024 | 1846 | 0.330 |
Why?
|
Eicosapentaenoic Acid | 2 | 2024 | 561 | 0.330 |
Why?
|
Renal Replacement Therapy | 1 | 2011 | 281 | 0.330 |
Why?
|
Occupational Exposure | 5 | 2024 | 1813 | 0.330 |
Why?
|
Risk | 10 | 2022 | 9604 | 0.330 |
Why?
|
Lymphoma, Non-Hodgkin | 3 | 2019 | 1372 | 0.320 |
Why?
|
Longitudinal Studies | 11 | 2019 | 14591 | 0.320 |
Why?
|
Communicable Diseases | 1 | 2017 | 871 | 0.320 |
Why?
|
Medicare | 3 | 2022 | 6765 | 0.320 |
Why?
|
Cytokines | 3 | 2022 | 7373 | 0.310 |
Why?
|
Stroke | 4 | 2021 | 9712 | 0.310 |
Why?
|
Retrospective Studies | 23 | 2024 | 80566 | 0.300 |
Why?
|
Nuts | 2 | 2021 | 264 | 0.300 |
Why?
|
Diet, Mediterranean | 3 | 2021 | 738 | 0.300 |
Why?
|
Biopsy | 2 | 2019 | 6762 | 0.300 |
Why?
|
Weight Gain | 2 | 2022 | 2350 | 0.300 |
Why?
|
Pravastatin | 2 | 2007 | 392 | 0.300 |
Why?
|
Algorithms | 6 | 2019 | 14018 | 0.300 |
Why?
|
Europe | 9 | 2020 | 3413 | 0.290 |
Why?
|
Retina | 1 | 2018 | 2655 | 0.290 |
Why?
|
Alleles | 9 | 2020 | 6861 | 0.290 |
Why?
|
Disease Progression | 9 | 2019 | 13495 | 0.290 |
Why?
|
Interleukin-6 | 3 | 2019 | 3206 | 0.290 |
Why?
|
Hydrolases | 1 | 2008 | 147 | 0.290 |
Why?
|
Follow-Up Studies | 17 | 2022 | 39063 | 0.290 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2023 | 15908 | 0.290 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2018 | 1393 | 0.280 |
Why?
|
Health Care Costs | 1 | 2020 | 3238 | 0.280 |
Why?
|
Treatment Outcome | 16 | 2024 | 64568 | 0.270 |
Why?
|
Periodontal Diseases | 1 | 2010 | 451 | 0.270 |
Why?
|
Osteonecrosis | 2 | 2019 | 229 | 0.270 |
Why?
|
Postmenopause | 3 | 2017 | 2511 | 0.260 |
Why?
|
Diabetes Mellitus | 4 | 2019 | 5835 | 0.260 |
Why?
|
Herpesvirus 4, Human | 1 | 2011 | 1077 | 0.260 |
Why?
|
DNA | 5 | 2023 | 7196 | 0.250 |
Why?
|
Atherosclerosis | 3 | 2013 | 3400 | 0.250 |
Why?
|
Obesity | 7 | 2022 | 12933 | 0.250 |
Why?
|
Adaptive Immunity | 1 | 2010 | 724 | 0.250 |
Why?
|
Feeding Behavior | 7 | 2021 | 3182 | 0.250 |
Why?
|
Smoking Cessation | 3 | 2019 | 2056 | 0.250 |
Why?
|
Insurance Claim Review | 1 | 2010 | 741 | 0.250 |
Why?
|
Child, Preschool | 10 | 2024 | 42188 | 0.250 |
Why?
|
Immune System | 1 | 2010 | 791 | 0.250 |
Why?
|
Odds Ratio | 10 | 2017 | 9643 | 0.250 |
Why?
|
Immunologic Factors | 2 | 2021 | 1589 | 0.240 |
Why?
|
Sensitivity and Specificity | 12 | 2021 | 14648 | 0.240 |
Why?
|
Solvents | 4 | 2016 | 294 | 0.240 |
Why?
|
Antidepressive Agents | 3 | 2023 | 2896 | 0.240 |
Why?
|
Indians, North American | 3 | 2021 | 351 | 0.240 |
Why?
|
Age Factors | 12 | 2021 | 18381 | 0.240 |
Why?
|
Socioeconomic Factors | 8 | 2024 | 7798 | 0.240 |
Why?
|
Menarche | 3 | 2020 | 532 | 0.230 |
Why?
|
Chemokine CXCL13 | 1 | 2024 | 59 | 0.230 |
Why?
|
Endrin | 1 | 2023 | 4 | 0.230 |
Why?
|
Dyspnea | 2 | 2009 | 1347 | 0.230 |
Why?
|
Methotrexate | 4 | 2023 | 1716 | 0.230 |
Why?
|
Age of Onset | 6 | 2024 | 3302 | 0.220 |
Why?
|
Spouses | 2 | 2016 | 283 | 0.220 |
Why?
|
Genetic Markers | 1 | 2010 | 2601 | 0.220 |
Why?
|
Referral and Consultation | 2 | 2014 | 3599 | 0.220 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2024 | 65 | 0.220 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2024 | 287 | 0.220 |
Why?
|
Serologic Tests | 3 | 2021 | 381 | 0.220 |
Why?
|
Fingers | 1 | 2006 | 506 | 0.220 |
Why?
|
Patient Dropouts | 1 | 2005 | 410 | 0.220 |
Why?
|
Health Surveys | 8 | 2021 | 4037 | 0.210 |
Why?
|
Environmental Pollutants | 4 | 2018 | 1277 | 0.210 |
Why?
|
Agriculture | 4 | 2024 | 187 | 0.210 |
Why?
|
Hypercholesterolemia | 2 | 2007 | 1141 | 0.210 |
Why?
|
Hashimoto Disease | 1 | 2024 | 107 | 0.210 |
Why?
|
Life Style | 8 | 2021 | 3904 | 0.210 |
Why?
|
Risk Reduction Behavior | 3 | 2021 | 1110 | 0.210 |
Why?
|
Immunophenotyping | 2 | 2024 | 1865 | 0.200 |
Why?
|
Amino Acids | 2 | 2021 | 1717 | 0.200 |
Why?
|
Treatment Refusal | 1 | 2005 | 429 | 0.200 |
Why?
|
Prognosis | 10 | 2021 | 29600 | 0.200 |
Why?
|
Endocarditis | 1 | 2006 | 348 | 0.200 |
Why?
|
Antioxidants | 1 | 2010 | 1668 | 0.200 |
Why?
|
Patient Participation | 2 | 2012 | 1443 | 0.200 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2024 | 220 | 0.200 |
Why?
|
Patient Preference | 2 | 2024 | 925 | 0.190 |
Why?
|
Reproducibility of Results | 7 | 2020 | 20074 | 0.190 |
Why?
|
Arylamine N-Acetyltransferase | 1 | 2022 | 87 | 0.190 |
Why?
|
Genome-Wide Association Study | 6 | 2024 | 12661 | 0.190 |
Why?
|
Research Design | 3 | 2023 | 6174 | 0.190 |
Why?
|
Breast Feeding | 3 | 2020 | 1354 | 0.190 |
Why?
|
Anxiety | 1 | 2016 | 4570 | 0.190 |
Why?
|
B-Cell Activating Factor | 1 | 2021 | 115 | 0.190 |
Why?
|
Clinical Medicine | 1 | 2002 | 145 | 0.190 |
Why?
|
Fabaceae | 1 | 2021 | 103 | 0.190 |
Why?
|
Complement System Proteins | 3 | 2019 | 734 | 0.180 |
Why?
|
Putrescine | 1 | 2020 | 42 | 0.180 |
Why?
|
Xenobiotics | 1 | 2021 | 70 | 0.180 |
Why?
|
Atrial Fibrillation | 1 | 2019 | 5031 | 0.180 |
Why?
|
Butyric Acid | 1 | 2020 | 51 | 0.180 |
Why?
|
Receptors, Bradykinin | 2 | 1997 | 19 | 0.180 |
Why?
|
Spermidine | 1 | 2020 | 62 | 0.180 |
Why?
|
Lupus Erythematosus, Cutaneous | 1 | 2022 | 73 | 0.180 |
Why?
|
Area Under Curve | 3 | 2021 | 1635 | 0.180 |
Why?
|
Linear Models | 4 | 2020 | 5866 | 0.180 |
Why?
|
Tobacco Smoke Pollution | 2 | 2021 | 819 | 0.180 |
Why?
|
Fasciitis | 1 | 2001 | 67 | 0.180 |
Why?
|
Asthma | 4 | 2021 | 6233 | 0.180 |
Why?
|
Qualitative Research | 3 | 2024 | 3016 | 0.180 |
Why?
|
Child | 11 | 2024 | 80079 | 0.180 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2021 | 3204 | 0.180 |
Why?
|
Phosphatidylethanolamines | 1 | 2020 | 129 | 0.180 |
Why?
|
Myocardial Infarction | 2 | 2021 | 11459 | 0.180 |
Why?
|
Neutrophil Activation | 1 | 2021 | 180 | 0.180 |
Why?
|
Osteoporosis | 1 | 2010 | 1604 | 0.180 |
Why?
|
Interferon Type I | 1 | 2024 | 557 | 0.180 |
Why?
|
Chi-Square Distribution | 4 | 2015 | 3410 | 0.180 |
Why?
|
Absenteeism | 1 | 2021 | 247 | 0.170 |
Why?
|
Estrogens | 1 | 2007 | 1521 | 0.170 |
Why?
|
Exercise | 4 | 2022 | 5886 | 0.170 |
Why?
|
Immunity, Innate | 2 | 2021 | 3045 | 0.170 |
Why?
|
Endogenous Retroviruses | 1 | 2021 | 111 | 0.170 |
Why?
|
Caprylates | 1 | 2020 | 115 | 0.170 |
Why?
|
Quality Indicators, Health Care | 1 | 2010 | 1790 | 0.170 |
Why?
|
Multi-Institutional Systems | 1 | 2019 | 43 | 0.170 |
Why?
|
Diet Surveys | 2 | 2021 | 1161 | 0.170 |
Why?
|
Cross-Sectional Studies | 8 | 2022 | 26049 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-maf | 1 | 2019 | 69 | 0.170 |
Why?
|
Polymorphism, Genetic | 6 | 2010 | 4242 | 0.170 |
Why?
|
Antibodies, Antiphospholipid | 2 | 2019 | 71 | 0.170 |
Why?
|
Quality Assurance, Health Care | 1 | 2010 | 2164 | 0.170 |
Why?
|
Pleurisy | 1 | 2019 | 54 | 0.170 |
Why?
|
Attitude to Health | 2 | 2007 | 2024 | 0.170 |
Why?
|
Predictive Value of Tests | 8 | 2021 | 15251 | 0.170 |
Why?
|
Germany | 1 | 2021 | 872 | 0.160 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 4 | 2023 | 2270 | 0.160 |
Why?
|
Patient Education as Topic | 4 | 2020 | 2315 | 0.160 |
Why?
|
Adolescent Development | 2 | 2013 | 281 | 0.160 |
Why?
|
Carnitine | 1 | 2020 | 252 | 0.160 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2010 | 4341 | 0.160 |
Why?
|
International Cooperation | 5 | 2019 | 1421 | 0.160 |
Why?
|
Regression Analysis | 3 | 2017 | 6338 | 0.160 |
Why?
|
Lung Diseases | 1 | 2009 | 1909 | 0.160 |
Why?
|
Survival Rate | 3 | 2020 | 12719 | 0.160 |
Why?
|
Urban Population | 3 | 2018 | 2033 | 0.160 |
Why?
|
Quality of Health Care | 1 | 2014 | 4321 | 0.160 |
Why?
|
B-Lymphocytes | 2 | 2024 | 4745 | 0.160 |
Why?
|
Interleukins | 2 | 2022 | 783 | 0.160 |
Why?
|
Family Planning Services | 1 | 2021 | 266 | 0.160 |
Why?
|
Tryptophan | 1 | 2020 | 482 | 0.150 |
Why?
|
Milk | 1 | 2021 | 442 | 0.150 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2024 | 974 | 0.150 |
Why?
|
Self Report | 4 | 2020 | 3723 | 0.150 |
Why?
|
Antibodies, Monoclonal | 3 | 2017 | 9172 | 0.150 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 1133 | 0.150 |
Why?
|
Kidney Transplantation | 4 | 2018 | 4236 | 0.150 |
Why?
|
Clinical Coding | 1 | 2019 | 181 | 0.150 |
Why?
|
Methionine | 1 | 2020 | 572 | 0.150 |
Why?
|
Diet Records | 1 | 2019 | 427 | 0.150 |
Why?
|
Kidney Glomerulus | 2 | 1997 | 568 | 0.150 |
Why?
|
Erythrocytes | 1 | 2007 | 2410 | 0.150 |
Why?
|
Contraception | 1 | 2021 | 347 | 0.150 |
Why?
|
ROC Curve | 4 | 2021 | 3575 | 0.150 |
Why?
|
Foundations | 1 | 2018 | 95 | 0.150 |
Why?
|
Cultural Diversity | 1 | 2022 | 369 | 0.150 |
Why?
|
Mendelian Randomization Analysis | 1 | 2023 | 1007 | 0.150 |
Why?
|
Registries | 6 | 2021 | 8207 | 0.150 |
Why?
|
Dairy Products | 1 | 2021 | 490 | 0.150 |
Why?
|
Hematologic Tests | 1 | 2019 | 239 | 0.150 |
Why?
|
Genotype | 6 | 2020 | 12978 | 0.150 |
Why?
|
Focus Groups | 3 | 2021 | 1409 | 0.150 |
Why?
|
Pericardial Effusion | 1 | 2019 | 247 | 0.150 |
Why?
|
Retinal Diseases | 2 | 2021 | 704 | 0.150 |
Why?
|
New York City | 2 | 2017 | 731 | 0.140 |
Why?
|
Antigens, CD | 1 | 2008 | 3998 | 0.140 |
Why?
|
Edema | 1 | 2001 | 765 | 0.140 |
Why?
|
Hemorrhage | 1 | 2009 | 3418 | 0.140 |
Why?
|
Hospital Information Systems | 1 | 2019 | 394 | 0.140 |
Why?
|
Obesity, Abdominal | 1 | 2020 | 373 | 0.140 |
Why?
|
Coronary Disease | 3 | 2009 | 5912 | 0.140 |
Why?
|
Ontario | 1 | 2018 | 397 | 0.140 |
Why?
|
Beer | 1 | 2017 | 134 | 0.140 |
Why?
|
Spinal Cord Diseases | 1 | 2019 | 291 | 0.140 |
Why?
|
Eosinophilia | 1 | 2001 | 559 | 0.140 |
Why?
|
Wrist Injuries | 1 | 2019 | 214 | 0.140 |
Why?
|
Antimalarials | 2 | 2021 | 907 | 0.140 |
Why?
|
Back Pain | 1 | 2020 | 545 | 0.130 |
Why?
|
Pleural Effusion | 1 | 2019 | 341 | 0.130 |
Why?
|
Wine | 1 | 2017 | 166 | 0.130 |
Why?
|
North America | 6 | 2020 | 1273 | 0.130 |
Why?
|
Death, Sudden, Cardiac | 1 | 2024 | 1551 | 0.130 |
Why?
|
Interleukin-10 | 1 | 2021 | 1172 | 0.130 |
Why?
|
Genome, Human | 2 | 2008 | 4421 | 0.130 |
Why?
|
Hot Temperature | 1 | 2022 | 1437 | 0.130 |
Why?
|
Boston | 4 | 2020 | 9313 | 0.130 |
Why?
|
Genetic Variation | 4 | 2015 | 6561 | 0.130 |
Why?
|
Macular Degeneration | 1 | 2023 | 1007 | 0.130 |
Why?
|
Syndrome | 1 | 2022 | 3268 | 0.130 |
Why?
|
Neuromyelitis Optica | 1 | 2019 | 264 | 0.130 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1835 | 0.130 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2021 | 575 | 0.130 |
Why?
|
Ribonucleoproteins | 1 | 2018 | 360 | 0.130 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2019 | 294 | 0.130 |
Why?
|
Rheumatic Fever | 1 | 2015 | 73 | 0.120 |
Why?
|
Infusions, Intravenous | 1 | 2020 | 2214 | 0.120 |
Why?
|
T-Lymphocytes | 3 | 2018 | 10175 | 0.120 |
Why?
|
Metabolomics | 2 | 2023 | 1656 | 0.120 |
Why?
|
Fatty Acids | 1 | 2023 | 1808 | 0.120 |
Why?
|
Pregnancy | 12 | 2023 | 29868 | 0.120 |
Why?
|
Air Pollution | 3 | 2016 | 2355 | 0.120 |
Why?
|
Physicians | 3 | 2023 | 4583 | 0.120 |
Why?
|
Aged, 80 and over | 9 | 2024 | 58894 | 0.120 |
Why?
|
HLA-B27 Antigen | 1 | 2014 | 63 | 0.120 |
Why?
|
Genes, MHC Class II | 1 | 2015 | 433 | 0.120 |
Why?
|
Dinoprostone | 1 | 1997 | 597 | 0.120 |
Why?
|
Arrhythmias, Cardiac | 1 | 2024 | 2234 | 0.120 |
Why?
|
Survival Analysis | 3 | 2017 | 10073 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2024 | 12142 | 0.120 |
Why?
|
Family | 2 | 2016 | 3193 | 0.120 |
Why?
|
Hypersensitivity | 1 | 2023 | 1167 | 0.120 |
Why?
|
Insurance, Health | 2 | 2020 | 2495 | 0.110 |
Why?
|
Atrophy | 1 | 2019 | 1631 | 0.110 |
Why?
|
Adrenal Cortex Hormones | 2 | 2020 | 1879 | 0.110 |
Why?
|
Poisson Distribution | 1 | 2015 | 504 | 0.110 |
Why?
|
Mercury | 1 | 2016 | 290 | 0.110 |
Why?
|
Autoantigens | 1 | 2018 | 888 | 0.110 |
Why?
|
Vulnerable Populations | 1 | 2019 | 704 | 0.110 |
Why?
|
Propensity Score | 1 | 2021 | 1911 | 0.110 |
Why?
|
Carotenoids | 1 | 2017 | 621 | 0.110 |
Why?
|
Iowa | 2 | 2024 | 104 | 0.110 |
Why?
|
Vision Disorders | 1 | 2021 | 1088 | 0.110 |
Why?
|
Disease Management | 2 | 2021 | 2506 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2008 | 10199 | 0.110 |
Why?
|
Massachusetts | 4 | 2022 | 8833 | 0.110 |
Why?
|
Research Personnel | 1 | 2018 | 588 | 0.110 |
Why?
|
Carbonated Beverages | 1 | 2014 | 210 | 0.110 |
Why?
|
Decision Making | 1 | 2007 | 3918 | 0.110 |
Why?
|
Antibodies | 1 | 2021 | 2414 | 0.110 |
Why?
|
Spondylitis, Ankylosing | 1 | 2014 | 155 | 0.110 |
Why?
|
North Carolina | 2 | 2024 | 322 | 0.100 |
Why?
|
Pamphlets | 1 | 2012 | 71 | 0.100 |
Why?
|
Interferon-alpha | 1 | 2017 | 902 | 0.100 |
Why?
|
Dietary Sucrose | 1 | 2014 | 243 | 0.100 |
Why?
|
Mental Health Services | 1 | 2024 | 1717 | 0.100 |
Why?
|
Practice Guidelines as Topic | 3 | 2022 | 7389 | 0.100 |
Why?
|
Child Abuse | 1 | 2021 | 1076 | 0.100 |
Why?
|
Sulfur Dioxide | 1 | 2012 | 178 | 0.100 |
Why?
|
Coronary Artery Bypass | 1 | 2021 | 2188 | 0.100 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1896 | 0.100 |
Why?
|
Upper Extremity | 1 | 2017 | 658 | 0.100 |
Why?
|
Advisory Committees | 3 | 2021 | 787 | 0.100 |
Why?
|
Fibrosis | 1 | 2019 | 2045 | 0.100 |
Why?
|
Data Mining | 1 | 2017 | 551 | 0.100 |
Why?
|
Birth Weight | 3 | 2009 | 2101 | 0.100 |
Why?
|
beta 2-Glycoprotein I | 2 | 2023 | 28 | 0.100 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2024 | 4366 | 0.100 |
Why?
|
Apolipoproteins | 1 | 2014 | 326 | 0.100 |
Why?
|
Weather | 1 | 2013 | 231 | 0.100 |
Why?
|
Drug Hypersensitivity | 1 | 2020 | 917 | 0.100 |
Why?
|
Residence Characteristics | 2 | 2019 | 2090 | 0.100 |
Why?
|
Spinal Cord | 1 | 2019 | 1807 | 0.090 |
Why?
|
Coronary Artery Disease | 2 | 2021 | 6403 | 0.090 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2013 | 289 | 0.090 |
Why?
|
Herpesviridae | 1 | 2011 | 104 | 0.090 |
Why?
|
Abortion, Spontaneous | 2 | 2016 | 532 | 0.090 |
Why?
|
Self-Help Groups | 1 | 2012 | 192 | 0.090 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2013 | 880 | 0.090 |
Why?
|
Community-Institutional Relations | 1 | 2012 | 206 | 0.090 |
Why?
|
Particulate Matter | 2 | 2013 | 2602 | 0.090 |
Why?
|
Phenotype | 6 | 2024 | 16571 | 0.090 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2011 | 157 | 0.090 |
Why?
|
Fluorescent Antibody Technique, Indirect | 2 | 2022 | 427 | 0.090 |
Why?
|
Peritoneal Dialysis | 1 | 2011 | 159 | 0.090 |
Why?
|
Animals | 9 | 2024 | 168201 | 0.090 |
Why?
|
Adaptation, Psychological | 1 | 2021 | 2629 | 0.090 |
Why?
|
Body Weight | 2 | 2018 | 4614 | 0.090 |
Why?
|
Cost of Illness | 1 | 2020 | 1935 | 0.090 |
Why?
|
PubMed | 1 | 2010 | 129 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2899 | 0.090 |
Why?
|
Blood Sedimentation | 2 | 2008 | 235 | 0.090 |
Why?
|
Confidence Intervals | 1 | 2015 | 2925 | 0.080 |
Why?
|
Coronary Vessels | 1 | 2021 | 3095 | 0.080 |
Why?
|
Social Isolation | 1 | 2012 | 364 | 0.080 |
Why?
|
Coagulants | 1 | 2009 | 45 | 0.080 |
Why?
|
Nucleotide Deaminases | 1 | 2009 | 11 | 0.080 |
Why?
|
Nitrogen Dioxide | 1 | 2012 | 522 | 0.080 |
Why?
|
Quality of Life | 3 | 2021 | 13347 | 0.080 |
Why?
|
Hydroxymethyl and Formyl Transferases | 1 | 2009 | 18 | 0.080 |
Why?
|
Sweden | 4 | 2013 | 1379 | 0.080 |
Why?
|
Menopause | 1 | 2017 | 1645 | 0.080 |
Why?
|
Lipoproteins, HDL | 1 | 2014 | 675 | 0.080 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2010 | 355 | 0.080 |
Why?
|
Drug Prescriptions | 1 | 2019 | 1669 | 0.080 |
Why?
|
Multiple Sclerosis | 2 | 2019 | 3222 | 0.080 |
Why?
|
Lower Extremity | 1 | 2017 | 1200 | 0.080 |
Why?
|
Factor VII | 1 | 2009 | 139 | 0.080 |
Why?
|
Emergency Service, Hospital | 2 | 2021 | 7871 | 0.080 |
Why?
|
Telephone | 1 | 2012 | 626 | 0.080 |
Why?
|
Adenocarcinoma | 1 | 2006 | 6340 | 0.080 |
Why?
|
Patient Compliance | 3 | 2011 | 2688 | 0.080 |
Why?
|
Plasmapheresis | 1 | 2009 | 206 | 0.080 |
Why?
|
Electrocardiography | 1 | 2022 | 6346 | 0.080 |
Why?
|
Educational Status | 3 | 2013 | 2509 | 0.080 |
Why?
|
Pathology, Molecular | 1 | 2011 | 329 | 0.080 |
Why?
|
Immunoglobulin M | 2 | 2023 | 1526 | 0.080 |
Why?
|
Tooth Loss | 1 | 2010 | 200 | 0.080 |
Why?
|
Neutrophils | 1 | 2021 | 3763 | 0.080 |
Why?
|
Pandemics | 3 | 2023 | 8645 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2024 | 10754 | 0.080 |
Why?
|
Administration, Oral | 1 | 2016 | 4010 | 0.080 |
Why?
|
Receptors, Calcitriol | 1 | 2010 | 360 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2021 | 4007 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1884 | 0.080 |
Why?
|
Metagenomics | 1 | 2011 | 463 | 0.070 |
Why?
|
Causality | 1 | 2014 | 1240 | 0.070 |
Why?
|
Medical Records | 2 | 2011 | 1407 | 0.070 |
Why?
|
Geography | 1 | 2010 | 652 | 0.070 |
Why?
|
Sex Distribution | 1 | 2013 | 2278 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2016 | 3514 | 0.070 |
Why?
|
Community Health Services | 1 | 2012 | 654 | 0.070 |
Why?
|
Cholesterol, LDL | 3 | 2022 | 2379 | 0.070 |
Why?
|
Drug Therapy, Combination | 2 | 2009 | 6305 | 0.070 |
Why?
|
Mass Screening | 3 | 2021 | 5424 | 0.070 |
Why?
|
Pain Measurement | 1 | 2018 | 3546 | 0.070 |
Why?
|
Poverty | 1 | 2019 | 2692 | 0.070 |
Why?
|
Brachial Artery | 1 | 2009 | 366 | 0.070 |
Why?
|
Transportation | 1 | 2009 | 217 | 0.070 |
Why?
|
Hazardous Waste | 1 | 2007 | 24 | 0.070 |
Why?
|
Haplotypes | 2 | 2015 | 2713 | 0.070 |
Why?
|
Age Distribution | 1 | 2013 | 2871 | 0.070 |
Why?
|
Family Characteristics | 1 | 2012 | 992 | 0.070 |
Why?
|
Prolactin | 1 | 2009 | 625 | 0.070 |
Why?
|
Peer Group | 1 | 2012 | 692 | 0.070 |
Why?
|
Fractures, Bone | 1 | 2019 | 2044 | 0.070 |
Why?
|
Foot Joints | 1 | 2007 | 35 | 0.070 |
Why?
|
Immunoglobulin G | 3 | 2023 | 4533 | 0.070 |
Why?
|
Diagnosis, Differential | 4 | 2019 | 12966 | 0.070 |
Why?
|
Hand Joints | 1 | 2007 | 58 | 0.070 |
Why?
|
Chromosomes, Human | 1 | 2008 | 441 | 0.070 |
Why?
|
Acute-Phase Reaction | 3 | 2010 | 91 | 0.070 |
Why?
|
Overweight | 2 | 2014 | 2417 | 0.070 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 693 | 0.070 |
Why?
|
Infertility, Female | 1 | 2012 | 760 | 0.070 |
Why?
|
Heart Failure | 2 | 2021 | 11669 | 0.070 |
Why?
|
Social Class | 2 | 2019 | 1992 | 0.060 |
Why?
|
Depressive Disorder | 1 | 2018 | 3735 | 0.060 |
Why?
|
Menopause, Premature | 1 | 2007 | 124 | 0.060 |
Why?
|
Pain | 1 | 2021 | 5061 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2164 | 0.060 |
Why?
|
Regional Blood Flow | 1 | 2009 | 1496 | 0.060 |
Why?
|
Multienzyme Complexes | 1 | 2009 | 666 | 0.060 |
Why?
|
Intestines | 1 | 2014 | 1909 | 0.060 |
Why?
|
Pregnancy Outcome | 1 | 2016 | 2921 | 0.060 |
Why?
|
Oxidative Stress | 1 | 2016 | 3113 | 0.060 |
Why?
|
Employment | 1 | 2011 | 1113 | 0.060 |
Why?
|
Demography | 1 | 2010 | 1643 | 0.060 |
Why?
|
Ramipril | 1 | 2005 | 102 | 0.060 |
Why?
|
Liver Cirrhosis, Biliary | 1 | 2006 | 108 | 0.060 |
Why?
|
Altruism | 1 | 2007 | 208 | 0.060 |
Why?
|
Hodgkin Disease | 1 | 2013 | 1378 | 0.060 |
Why?
|
Coronary Circulation | 2 | 2021 | 1569 | 0.060 |
Why?
|
Endothelium, Vascular | 2 | 2009 | 4433 | 0.060 |
Why?
|
Synovitis | 3 | 2010 | 217 | 0.060 |
Why?
|
Vasodilation | 1 | 2009 | 962 | 0.060 |
Why?
|
Lymphatic Diseases | 1 | 2006 | 320 | 0.060 |
Why?
|
Glutathione Transferase | 1 | 2007 | 565 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2023 | 2326 | 0.060 |
Why?
|
Counseling | 1 | 2012 | 1538 | 0.060 |
Why?
|
Serum Albumin | 1 | 2007 | 672 | 0.060 |
Why?
|
Graves Disease | 1 | 2006 | 238 | 0.060 |
Why?
|
Gonadal Steroid Hormones | 1 | 2008 | 702 | 0.060 |
Why?
|
Gene Expression | 2 | 2021 | 7568 | 0.050 |
Why?
|
Sarcoidosis | 1 | 2009 | 521 | 0.050 |
Why?
|
Vitamin B Complex | 1 | 2005 | 299 | 0.050 |
Why?
|
Motivation | 2 | 2018 | 2003 | 0.050 |
Why?
|
Electronic Health Records | 2 | 2019 | 4803 | 0.050 |
Why?
|
Drug Synergism | 1 | 2007 | 1755 | 0.050 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1335 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
Health Services Research | 1 | 2010 | 1808 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
Epidemiologic Studies | 1 | 2006 | 673 | 0.050 |
Why?
|
Vasculitis | 1 | 2006 | 522 | 0.050 |
Why?
|
Models, Structural | 1 | 2022 | 340 | 0.050 |
Why?
|
Lung Neoplasms | 1 | 2006 | 13382 | 0.050 |
Why?
|
Creatinine | 1 | 2007 | 1896 | 0.050 |
Why?
|
Androgens | 1 | 2009 | 1285 | 0.050 |
Why?
|
Fatal Outcome | 1 | 2006 | 1835 | 0.050 |
Why?
|
Renal Insufficiency | 1 | 2007 | 808 | 0.050 |
Why?
|
Food Analysis | 1 | 2021 | 103 | 0.050 |
Why?
|
Single-Blind Method | 1 | 2004 | 1575 | 0.050 |
Why?
|
Philippines | 1 | 2020 | 90 | 0.050 |
Why?
|
Genetic Loci | 1 | 2010 | 2624 | 0.040 |
Why?
|
Emotions | 1 | 2012 | 2740 | 0.040 |
Why?
|
Meta-Analysis as Topic | 1 | 2005 | 1380 | 0.040 |
Why?
|
Arthroplasty | 1 | 2023 | 310 | 0.040 |
Why?
|
Diet, Vegetarian | 1 | 2022 | 180 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 627 | 0.040 |
Why?
|
Antibodies, Viral | 1 | 2011 | 3150 | 0.040 |
Why?
|
Physician's Role | 1 | 2007 | 917 | 0.040 |
Why?
|
Language | 1 | 2009 | 1541 | 0.040 |
Why?
|
Length of Stay | 1 | 2013 | 6418 | 0.040 |
Why?
|
Radiography, Thoracic | 1 | 2006 | 1302 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2013 | 5293 | 0.040 |
Why?
|
Receptors, CXCR5 | 1 | 2019 | 88 | 0.040 |
Why?
|
Albumins | 1 | 2022 | 575 | 0.040 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2009 | 2518 | 0.040 |
Why?
|
Patient Readmission | 1 | 2013 | 3269 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 1997 | 11874 | 0.040 |
Why?
|
Immunoconjugates | 1 | 2007 | 951 | 0.040 |
Why?
|
Fatigue | 1 | 2006 | 1550 | 0.040 |
Why?
|
Air Pollutants | 1 | 2013 | 2893 | 0.040 |
Why?
|
Cell Line, Transformed | 2 | 1997 | 866 | 0.040 |
Why?
|
Nutritional Status | 1 | 2007 | 1596 | 0.040 |
Why?
|
Mixed Connective Tissue Disease | 1 | 2018 | 32 | 0.040 |
Why?
|
Social Support | 1 | 2009 | 2174 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2007 | 6224 | 0.040 |
Why?
|
Visual Field Tests | 1 | 2021 | 411 | 0.040 |
Why?
|
Infant, Premature | 1 | 2008 | 2107 | 0.040 |
Why?
|
Linkage Disequilibrium | 1 | 2023 | 1994 | 0.040 |
Why?
|
Repressor Proteins | 1 | 2009 | 2985 | 0.040 |
Why?
|
Epigenomics | 1 | 2024 | 942 | 0.040 |
Why?
|
Fever of Unknown Origin | 1 | 2018 | 94 | 0.040 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2018 | 101 | 0.040 |
Why?
|
Anticholesteremic Agents | 1 | 2005 | 967 | 0.040 |
Why?
|
Complement C4 | 1 | 2018 | 216 | 0.040 |
Why?
|
Occupational Diseases | 1 | 2006 | 1490 | 0.040 |
Why?
|
Child Abuse, Sexual | 1 | 2021 | 403 | 0.040 |
Why?
|
Hypertension | 2 | 2011 | 8529 | 0.040 |
Why?
|
Leukopenia | 1 | 2018 | 213 | 0.040 |
Why?
|
Granzymes | 1 | 2019 | 277 | 0.040 |
Why?
|
Raynaud Disease | 1 | 2018 | 79 | 0.040 |
Why?
|
Mental Health | 1 | 2012 | 3251 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2024 | 2079 | 0.040 |
Why?
|
Drug Dosage Calculations | 1 | 2018 | 117 | 0.040 |
Why?
|
Prednisone | 1 | 2022 | 1562 | 0.040 |
Why?
|
Research Report | 1 | 2021 | 367 | 0.040 |
Why?
|
Interferons | 1 | 2021 | 703 | 0.040 |
Why?
|
Social Stigma | 1 | 2024 | 769 | 0.040 |
Why?
|
Premature Birth | 1 | 2009 | 1782 | 0.040 |
Why?
|
Radioligand Assay | 1 | 1997 | 366 | 0.040 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2021 | 324 | 0.040 |
Why?
|
Tritium | 1 | 1997 | 706 | 0.040 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2018 | 147 | 0.030 |
Why?
|
Agricultural Workers' Diseases | 1 | 2016 | 28 | 0.030 |
Why?
|
Bone Density | 1 | 2010 | 3548 | 0.030 |
Why?
|
Action Potentials | 1 | 2024 | 1825 | 0.030 |
Why?
|
Postpartum Period | 1 | 2023 | 1178 | 0.030 |
Why?
|
Fertilizers | 1 | 2016 | 24 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2021 | 973 | 0.030 |
Why?
|
Lymphopenia | 1 | 2018 | 281 | 0.030 |
Why?
|
Brazil | 1 | 2020 | 1228 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 801 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2024 | 2697 | 0.030 |
Why?
|
Waist Circumference | 1 | 2020 | 933 | 0.030 |
Why?
|
Hepatitis, Autoimmune | 1 | 2018 | 172 | 0.030 |
Why?
|
Life Change Events | 1 | 2021 | 952 | 0.030 |
Why?
|
Pilot Projects | 2 | 2009 | 8618 | 0.030 |
Why?
|
Laboratories | 1 | 2019 | 458 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2007 | 2090 | 0.030 |
Why?
|
Extremities | 1 | 2001 | 867 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2005 | 2016 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2019 | 1336 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2005 | 1810 | 0.030 |
Why?
|
Phagocytosis | 1 | 2021 | 1526 | 0.030 |
Why?
|
Scleroderma, Systemic | 1 | 2018 | 344 | 0.030 |
Why?
|
Drug Utilization | 1 | 2020 | 1186 | 0.030 |
Why?
|
HLA-B Antigens | 1 | 2015 | 317 | 0.030 |
Why?
|
Cell Separation | 1 | 2019 | 1718 | 0.030 |
Why?
|
Echocardiography | 1 | 2006 | 4987 | 0.030 |
Why?
|
Aspirin | 1 | 2005 | 3127 | 0.030 |
Why?
|
Health Status | 1 | 2007 | 4075 | 0.030 |
Why?
|
Surgical Procedures, Operative | 1 | 2005 | 1924 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2020 | 2700 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 1040 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1517 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2024 | 5239 | 0.030 |
Why?
|
Aminolevulinic Acid | 1 | 2014 | 144 | 0.030 |
Why?
|
Stillbirth | 1 | 2016 | 368 | 0.030 |
Why?
|
Infection Control | 1 | 2020 | 982 | 0.030 |
Why?
|
Deglutition Disorders | 1 | 2018 | 626 | 0.030 |
Why?
|
Heart Rate | 1 | 2024 | 4180 | 0.030 |
Why?
|
Gases | 1 | 2013 | 204 | 0.030 |
Why?
|
Pain, Postoperative | 1 | 2023 | 1737 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2020 | 5332 | 0.030 |
Why?
|
Cell Communication | 1 | 2019 | 1654 | 0.030 |
Why?
|
Outpatients | 1 | 2020 | 1596 | 0.020 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2012 | 360 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1662 | 0.020 |
Why?
|
Up-Regulation | 1 | 2021 | 4117 | 0.020 |
Why?
|
Hospitals | 1 | 2005 | 3877 | 0.020 |
Why?
|
Multifactorial Inheritance | 1 | 2019 | 1380 | 0.020 |
Why?
|
Dermatology | 1 | 2021 | 918 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 2018 | 1182 | 0.020 |
Why?
|
Respiratory Tract Diseases | 1 | 2016 | 750 | 0.020 |
Why?
|
Clinical Chemistry Tests | 1 | 2010 | 59 | 0.020 |
Why?
|
Parity | 1 | 2013 | 924 | 0.020 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2010 | 146 | 0.020 |
Why?
|
Lung Diseases, Interstitial | 1 | 2018 | 918 | 0.020 |
Why?
|
Natural Language Processing | 1 | 2019 | 1163 | 0.020 |
Why?
|
Portugal | 1 | 2009 | 91 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36402 | 0.020 |
Why?
|
Anthropometry | 1 | 2014 | 1338 | 0.020 |
Why?
|
South America | 1 | 2009 | 179 | 0.020 |
Why?
|
Occupational Health | 1 | 2016 | 806 | 0.020 |
Why?
|
Antibodies, Anticardiolipin | 1 | 2009 | 62 | 0.020 |
Why?
|
Isoenzymes | 1 | 2014 | 1687 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2014 | 1169 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2019 | 5863 | 0.020 |
Why?
|
Particle Size | 1 | 2013 | 1648 | 0.020 |
Why?
|
Oral Health | 1 | 2014 | 492 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5463 | 0.020 |
Why?
|
Health | 1 | 2011 | 398 | 0.020 |
Why?
|
Epithelial Cells | 2 | 1997 | 3672 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9417 | 0.020 |
Why?
|
Spain | 1 | 2009 | 487 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2916 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2012 | 802 | 0.020 |
Why?
|
New England | 1 | 2010 | 1051 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2024 | 11514 | 0.020 |
Why?
|
Environmental Monitoring | 1 | 2013 | 1460 | 0.020 |
Why?
|
Pre-Eclampsia | 1 | 2016 | 1230 | 0.020 |
Why?
|
Energy Intake | 1 | 2014 | 2132 | 0.020 |
Why?
|
Manometry | 1 | 2009 | 454 | 0.020 |
Why?
|
Radiography | 2 | 2008 | 6961 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5034 | 0.020 |
Why?
|
Transfection | 1 | 2014 | 5766 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2021 | 4488 | 0.020 |
Why?
|
Models, Genetic | 1 | 2015 | 3431 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6474 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3419 | 0.010 |
Why?
|
Vitamin D Deficiency | 1 | 2014 | 1388 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2021 | 6483 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18937 | 0.010 |
Why?
|
False Negative Reactions | 1 | 2005 | 573 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2008 | 2340 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2009 | 1079 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1997 | 12758 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10432 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 2008 | 1810 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2008 | 4611 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5758 | 0.010 |
Why?
|
Cholesterol | 1 | 2008 | 2903 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3680 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2008 | 26180 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20556 | 0.010 |
Why?
|
Inositol Phosphates | 1 | 1996 | 176 | 0.010 |
Why?
|
Bradykinin | 1 | 1996 | 208 | 0.010 |
Why?
|
Ribonucleases | 1 | 1996 | 277 | 0.010 |
Why?
|
Ultrasonography | 1 | 2009 | 5964 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 1996 | 659 | 0.010 |
Why?
|
Computer Simulation | 1 | 2009 | 6233 | 0.010 |
Why?
|
Models, Statistical | 1 | 2010 | 5073 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1996 | 1301 | 0.010 |
Why?
|
Cytosol | 1 | 1996 | 886 | 0.010 |
Why?
|
Epithelium | 1 | 1996 | 1603 | 0.010 |
Why?
|
Mice | 1 | 2018 | 81368 | 0.010 |
Why?
|
Binding Sites | 1 | 1996 | 6051 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1996 | 6074 | 0.000 |
Why?
|
Calcium | 1 | 1996 | 5717 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1996 | 7583 | 0.000 |
Why?
|